The FDA cited administrative constraints for the delay, Cambridge, Mass.-based Moderna said in a statement.
Shop the Jordan Sale for Items Up to $185 Off
SHOP NOW
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Business
